Allergan Plans Job Cuts as Key Drugs to Lose Exclusivity
Continue Reading Below
Allergan plans to lay off more than 1,000 workers as the drugmaker works to restructure its business ahead of sales declines expected for several key products, including blockbuster dry-eye drug Restasis.
Fidelity Moves Brian Hogan Out of Equity Division
The president of Fidelity Investments' equity division is moving to a new role within the fund giant's personal investing business later this quarter, leaving a post he has held since 2009.
Spotify Files to Go Public With Direct Listing, Cutting Out Underwriters
Spotify has confidentially filed paperwork with the Securities and Exchange Commission to list its shares on the New York Stock Exchange.
Continue Reading Below
Washington Sues Motel 6 for Sharing Guest Info With Feds
The state of Washington is suing Motel 6, alleging the low-cost hotel chain repeatedly provided detailed information about guests to federal immigration authorities for at least two years in violation of a state consumer protection law.
Time Inc. Sells Essence to Company Formed by Co-Founder of Sundial Brands
Time Inc. has sold Essence, the monthly African-American women's lifestyle magazine, to a company formed by Sundial Brands co-founder Richelieu Dennis.
Verizon, Samsung Will Team Up to Bring Faster 5G to California
Samsung was chosen as a major supplier in the telecom giant's push to offer 5G internet over its wireless network.
Petrobras to Pay $2.95 Billion to Settle U.S. Corruption Suit
Brazilian state-run oil company Petróleo Brasileiro said it would pay one of the highest-value settlements in history to end a class-action lawsuit by U.S. investors who had sought to recoup corruption-related losses.
U.S. Car Sales Are Set for Their First Annual Decline Since Financial Crisis
The U.S. auto industry in 2017 likely suffered its first annual sales decline since the financial crisis eight years ago, as demand finally ebbs after a remarkable multiyear growth spurt.
Dominion Energy to Buy Scana, Which Had Ended a Nuclear Project
Dominion Energy Inc. has struck a deal to buy troubled energy company Scana Corp., ushering in the final chapter for Scana's South Carolina nuclear project after it was abandoned when construction costs skyrocketed.
Drug Firm Will Charge $850,000 for Vision-Loss Gene Therapy
Spark Therapeutics will charge $850,000 a patient for a new treatment for vision loss-below the $1 million price tag it considered, but still a milestone for ever-rising U.S. drug prices.
(END) Dow Jones Newswires
January 03, 2018 17:15 ET (22:15 GMT)